MERRELL PHARMACEUTICALS INC.
Patent Owner
Stats
- 8 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jan 19, 2006 most recent publication
Details
- 8 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 859 Total Citation Count
- Apr 10, 1979 Earliest Filing
- 125 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
6037353 Method of providing an antihistaminic effect in a hepatically impaired patientMar 02, 95Mar 14, 00[A61K]
5981273 Composition comprising an endosomolytic agent for introducing nucleic acid complexes into higher eucaryotic cellsMay 25, 95Nov 09, 99[A61K, C07H, C12N]
5760210 Process for the preparation of ribonucleotide reductase inhibitorsJul 30, 96Jun 02, 98[C07H]
5508411 Process for preparing (S)-1-[2(S)-(1,3-dihyrdro-1,3-dioxo-isoindo-2-yl)-1-oxo-3-phenylpropyl]-1,2,3,4,-tetrahydro-2-pyridine-carboxylic acid methyl esterMar 30, 96Apr 16, 96[C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2006/0014,793 Process and diastereomeric salts useful for the optical resolution of racemic alpha-(4-(1, 1-dimethylethyl) phenyl] -4- (hydroxydiphenylmethyl) -1-piperidinebutanol and derivative compoundsAbandonedSep 15, 05Jan 19, 06[A61K, C07D]
2005/0032,738 Method of treating cancer by conjunctive therapy with 2'-haloemethylidene derivatives and a S-phase or M-phase specific antineoplastic agentAbandonedSep 17, 04Feb 10, 05[A61K]
2004/0186,137 Process and diastereomeric salts useful for the optical resolution of racemic alpha-(4-(1,1-dimethylethyl)phenyl)-4-(hydroxydiphenylmethyl)-1-p-iperidinebutanol and derivative compoundsAbandonedJan 29, 04Sep 23, 04[A61K, C07D]
2004/0063,659 Novel 2'-halomethylidene,2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivativesAbandonedSep 18, 03Apr 01, 04[A61K, C07D]
2003/0130,315 Method of providing an antihistaminic effect in a hepatically impaired patientAbandonedFeb 25, 03Jul 10, 03[A61K]
2003/0055,083 Method of providing an antihistaminic effect in a hepatically impaired patientAbandonedFeb 11, 00Mar 20, 03[A61K, A01N]
6313161 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase, 19-hydroxylase inhibitors and methods of their use in the treatment of estrogen mediated disordersExpiredOct 26, 99Nov 06, 01[A61K, C07D]
6232349 Anti-herpes virus and cytomegalovirus polyurea oligomersExpiredJan 07, 93May 15, 01[A61K, A01N]
6187791 Method of providing an antihistaminic effect in a hepatically impaired patientExpiredJan 12, 00Feb 13, 01[A61K]
6086864 Pharmaceutical formulations comprising polythiourea and methods of use thereofExpiredNov 26, 97Jul 11, 00[A61K, C08G, A61P]
6013251 Narrow poly-and-mono-dispersed anionic oligomers, and their uses, formulations and processesExpiredApr 01, 97Jan 11, 00[A61K]
5990328 Process for the preparation of 4-amino-.DELTA.4-3-ketosteroids via 4-nitro-.DELTA.4-3-ketosteroidsExpiredFeb 24, 99Nov 23, 99[C07J]
5986044 Narrow poly- and mono-dispersed anionic oligomersExpiredNov 26, 97Nov 16, 99[A61K, A01N, C09G]
5965550 Process for the preparation of 4-amino-.DELTA..sup.4 -3-ketosteroids via 4-nitro-.DELTA..sup.4 -3-ketosteroidsExpiredJan 22, 98Oct 12, 99[A61K, C07J]
5932614 Sulfonic stilbene compounds in the treatment of viral diseasesExpiredNov 05, 96Aug 03, 99[A61K]
5886156 Synthetic peptide lung surfactants having covalently bonded antioxidantsExpiredDec 26, 96Mar 23, 99[A61K, C07K]
5874627 Process for preparing polyamine derivatives and intermediates thereofExpiredSep 11, 97Feb 23, 99[C07C]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.